Roche: J.P. Morgan Healthcare Conference (35th Annual J.P. Morgan Healthcare Conference, Roche) - Jan 11, 2017 - Anticipated data from P1 trial (NCT02760797) of emactuzumab in combination with RO7009789 (aCD40) in advanced solid tumors in 2017; Anticipated data from P1 trial (NCT02665416) of vanucizumab in combination with RO7009789 in metastatic solid tumors in 2017
Anticipated P1 data • Oncology
|